Georg encouraged by successful male birth control study

A successful first-in-human clinical study of YCT-529, a hormone-free birth control pill for men developed by Dr. Gunda Georg of the College of Pharmacy and YourChoice Therapeutics, demonstrated its safety.

“Numerous published studies and surveys show that the world wants and needs more male contraceptive options. We also can’t deny that women are tired of bearing the burden of hormones,” Georg said in a press release. “Society is ready for a male contraceptive, and we applaud the organizations that recognize this and support our efforts to deliver the first hormone-free male birth control pill.”

Read the full Business Wire press release.